Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.070
-0.010 (-0.93%)
At close: May 22, 2026, 4:00 PM EDT
1.090
+0.020 (1.87%)
After-hours: May 22, 2026, 6:13 PM EDT
Revelation Biosciences Employees
Revelation Biosciences had 9 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,389,418
Market Cap
3.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | 0 | - | 8 | 1 |
| Dec 31, 2024 | 9 | -1 | -10.00% | 8 | 1 |
| Dec 31, 2023 | 10 | 4 | 66.67% | 9 | 1 |
| Dec 31, 2022 | 6 | - | - | 6 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| VivoSim Labs | 14 |
| Decoy Therapeutics | 11 |
| Galmed Pharmaceuticals | 6 |
| Alzamend Neuro | 6 |
| Enveric Biosciences | 6 |
REVB News
- 14 days ago - Revelation Biosciences reports FY25 EPS ($14.35) vs ($1,052.16) last year - TheFly
- 14 days ago - Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders - Accesswire
- 18 days ago - Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026 - Accesswire
- 7 weeks ago - Revelation Biosciences announces formation of AKI advisory board - TheFly
- 7 weeks ago - Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board - Accesswire
- 2 months ago - Revelation Gemini data show ‘broad effect,’ says Roth Capital - TheFly
- 2 months ago - Revelation Biosciences presents additional data from Prime Clinical Study - TheFly
- 2 months ago - Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study - Accesswire